Europe Phosphodiesterase Inhibitor Market Research Report Forecast 2017 to 2022

December 2017 | 109 pages | ID: EDD62D276F3EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Phosphodiesterase Inhibitor Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Phosphodiesterase Inhibitor industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Phosphodiesterase Inhibitor market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Phosphodiesterase Inhibitor Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Actelion Pharmaceuticals
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed
GlaxoSmithKline
Pfizer
Reata Pharmaceuticals
Arena Pharmaceuticals

Europe Phosphodiesterase Inhibitor Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Phosphodiesterase Inhibitor Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 PHOSPHODIESTERASE INHIBITOR MARKET OVERVIEW

1.1 Product Overview and Scope of Phosphodiesterase Inhibitor
1.2 Classification of Phosphodiesterase Inhibitor
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Phosphodiesterase Inhibitor
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Phosphodiesterase Inhibitor Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Phosphodiesterase Inhibitor (2012-2022)
  1.5.1 Europe Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2022)
  1.5.2 Europe Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON PHOSPHODIESTERASE INHIBITOR INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 PHOSPHODIESTERASE INHIBITOR MANUFACTURING COST ANALYSIS

3.1 Phosphodiesterase Inhibitor Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Phosphodiesterase Inhibitor

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Phosphodiesterase Inhibitor Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE PHOSPHODIESTERASE INHIBITOR MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Phosphodiesterase Inhibitor Market Competition by Manufacturers
  5.1.1 Europe Phosphodiesterase Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Phosphodiesterase Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Phosphodiesterase Inhibitor (Volume and Value) by Type
  5.2.1 Europe Phosphodiesterase Inhibitor Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Phosphodiesterase Inhibitor Revenue and Market Share by Type (2012-2017)
5.3 Europe Phosphodiesterase Inhibitor (Volume and Value) by Countries
  5.3.1 Europe Phosphodiesterase Inhibitor Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Phosphodiesterase Inhibitor Revenue and Market Share by Countries (2012-2017)
5.4 Europe Phosphodiesterase Inhibitor (Volume) by Application

6 GERMANY PHOSPHODIESTERASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Phosphodiesterase Inhibitor Sales and Value (2012-2017)
  6.1.1 Germany Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
  6.1.2 Germany Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
6.2 Germany Phosphodiesterase Inhibitor Sales and Market Share by Manufacturers
6.3 Germany Phosphodiesterase Inhibitor Sales and Market Share by Type
6.4 Germany Phosphodiesterase Inhibitor Sales and Market Share by Application

7 FRANCE PHOSPHODIESTERASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

7.1 France Phosphodiesterase Inhibitor Sales and Value (2012-2017)
  7.1.1 France Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
  7.1.2 France Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
  7.1.3 France Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
7.2 France Phosphodiesterase Inhibitor Sales and Market Share by Manufacturers
7.3 France Phosphodiesterase Inhibitor Sales and Market Share by Type
7.4 France Phosphodiesterase Inhibitor Sales and Market Share by Application

8 UK PHOSPHODIESTERASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

8.1 UK Phosphodiesterase Inhibitor Sales and Value (2012-2017)
  8.1.1 UK Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
  8.1.2 UK Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
  8.1.3 UK Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
8.2 UK Phosphodiesterase Inhibitor Sales and Market Share by Manufacturers
8.3 UK Phosphodiesterase Inhibitor Sales and Market Share by Type
8.4 UK Phosphodiesterase Inhibitor Sales and Market Share by Application

9 RUSSIA PHOSPHODIESTERASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Phosphodiesterase Inhibitor Sales and Value (2012-2017)
  9.1.1 Russia Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
  9.1.2 Russia Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
9.2 Russia Phosphodiesterase Inhibitor Sales and Market Share by Manufacturers
9.3 Russia Phosphodiesterase Inhibitor Sales and Market Share by Type
9.4 Russia Phosphodiesterase Inhibitor Sales and Market Share by Application

10 ITALY PHOSPHODIESTERASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Phosphodiesterase Inhibitor Sales and Value (2012-2017)
  10.1.1 Italy Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
  10.1.2 Italy Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
10.2 Italy Phosphodiesterase Inhibitor Sales and Market Share by Manufacturers
10.3 Italy Phosphodiesterase Inhibitor Sales and Market Share by Type
10.4 Italy Phosphodiesterase Inhibitor Sales and Market Share by Application

11 SPAIN PHOSPHODIESTERASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Phosphodiesterase Inhibitor Sales and Value (2012-2017)
  11.1.1 Spain Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
  11.1.2 Spain Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
11.2 Spain Phosphodiesterase Inhibitor Sales and Market Share by Manufacturers
11.3 Spain Phosphodiesterase Inhibitor Sales and Market Share by Type
11.4 Spain Phosphodiesterase Inhibitor Sales and Market Share by Application

12 BENELUX PHOSPHODIESTERASE INHIBITOR (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Phosphodiesterase Inhibitor Sales and Value (2012-2017)
  12.1.1 Benelux Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
12.2 Benelux Phosphodiesterase Inhibitor Sales and Market Share by Manufacturers
12.3 Benelux Phosphodiesterase Inhibitor Sales and Market Share by Type
12.4 Benelux Phosphodiesterase Inhibitor Sales and Market Share by Application

13 EUROPE PHOSPHODIESTERASE INHIBITOR MANUFACTURERS ANALYSIS

13.1 Actelion Pharmaceuticals
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 United Therapeutics Corporation
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Gilead sciences
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Bayer AG
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 SteadyMed
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 GlaxoSmithKline
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Pfizer
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Reata Pharmaceuticals
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Arena Pharmaceuticals
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE PHOSPHODIESTERASE INHIBITOR MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Phosphodiesterase Inhibitor Market Forecast by Type (2017-2022)
15.9 Europe Phosphodiesterase Inhibitor Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES

Figure Picture of Phosphodiesterase Inhibitor
Table Classification of Phosphodiesterase Inhibitor
Figure Europe Sales Market Share of Phosphodiesterase Inhibitor by Type in 2016
Table Application of Phosphodiesterase Inhibitor
Figure Europe Sales Market Share of Phosphodiesterase Inhibitor by Application in 2016
Figure Germany Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)
Figure France Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)
Figure UK Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)
Figure Russia Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)
Figure Italy Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)
Figure Spain Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)
Figure Benelux Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)
Figure Europe Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2022)
Figure Europe Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2022)
Table Europe Phosphodiesterase Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table Europe Phosphodiesterase Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Phosphodiesterase Inhibitor Sales Share by Manufacturers
Figure 2016 Phosphodiesterase Inhibitor Sales Share by Manufacturers
Table Europe Phosphodiesterase Inhibitor Revenue by Manufacturers (2015 and 2016)
Table Europe Phosphodiesterase Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table 2016 Europe Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table Europe Phosphodiesterase Inhibitor Sales and Market Share by Type (2012-2017)
Table Europe Phosphodiesterase Inhibitor Sales Share by Type (2012-2017)
Figure Sales Market Share of Phosphodiesterase Inhibitor by Type (2012-2017)
Figure Europe Phosphodiesterase Inhibitor Sales Growth Rate by Type (2012-2017)
Table Europe Phosphodiesterase Inhibitor Revenue and Market Share by Type (2012-2017)
Table Europe Phosphodiesterase Inhibitor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Phosphodiesterase Inhibitor by Type (2012-2017)
Figure Europe Phosphodiesterase Inhibitor Revenue Growth Rate by Type (2012-2017)
Table Europe Phosphodiesterase Inhibitor Sales and Market Share by Countries (2012-2017)
Table Europe Phosphodiesterase Inhibitor Sales Share by Countries (2012-2017)
Figure Sales Market Share of Phosphodiesterase Inhibitor by Countries (2012-2017)
Table Europe Phosphodiesterase Inhibitor Revenue and Market Share by Countries (2012-2017)
Table Europe Phosphodiesterase Inhibitor Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Phosphodiesterase Inhibitor by Countries (2012-2017)
Table Europe Phosphodiesterase Inhibitor Sales and Market Share by Application (2012-2017)
Table Europe Phosphodiesterase Inhibitor Sales Share by Application (2012-2017)
Figure Sales Market Share of Phosphodiesterase Inhibitor by Application (2012-2017)
Figure Germany Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
Figure Germany Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
Figure Germany Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
Table Germany Phosphodiesterase Inhibitor Sales by Manufacturers (2015 and 2016)
Table Germany Phosphodiesterase Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Germany Phosphodiesterase Inhibitor Sales by Type (2015 and 2016)
Table Germany Phosphodiesterase Inhibitor Market Share by Type (2015 and 2016)
Table Germany Phosphodiesterase Inhibitor Sales by Application (2015 and 2016)
Table Germany Phosphodiesterase Inhibitor Market Share by Application (2015 and 2016)
Figure France Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
Figure France Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
Figure France Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
Table France Phosphodiesterase Inhibitor Sales by Manufacturers (2015 and 2016)
Table France Phosphodiesterase Inhibitor Market Share by Manufacturers (2015 and 2016)
Table France Phosphodiesterase Inhibitor Sales by Type (2015 and 2016)
Table France Phosphodiesterase Inhibitor Market Share by Type (2015 and 2016)
Table France Phosphodiesterase Inhibitor Sales by Application (2015 and 2016)
Table France Phosphodiesterase Inhibitor Market Share by Application (2015 and 2016)
Figure UK Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
Figure UK Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
Figure UK Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
Table UK Phosphodiesterase Inhibitor Sales by Manufacturers (2015 and 2016)
Table UK Phosphodiesterase Inhibitor Market Share by Manufacturers (2015 and 2016)
Table UK Phosphodiesterase Inhibitor Sales by Type (2015 and 2016)
Table UK Phosphodiesterase Inhibitor Market Share by Type (2015 and 2016)
Table UK Phosphodiesterase Inhibitor Sales by Application (2015 and 2016)
Table UK Phosphodiesterase Inhibitor Market Share by Application (2015 and 2016)
Figure Russia Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
Figure Russia Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
Figure Russia Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
Table Russia Phosphodiesterase Inhibitor Sales by Manufacturers (2015 and 2016)
Table Russia Phosphodiesterase Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Russia Phosphodiesterase Inhibitor Sales by Type (2015 and 2016)
Table Russia Phosphodiesterase Inhibitor Market Share by Type (2015 and 2016)
Table Russia Phosphodiesterase Inhibitor Sales by Application (2015 and 2016)
Table Russia Phosphodiesterase Inhibitor Market Share by Application (2015 and 2016)
Figure Italy Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
Figure Italy Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
Figure Italy Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
Table Italy Phosphodiesterase Inhibitor Sales by Manufacturers (2015 and 2016)
Table Italy Phosphodiesterase Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Italy Phosphodiesterase Inhibitor Sales by Type (2015 and 2016)
Table Italy Phosphodiesterase Inhibitor Market Share by Type (2015 and 2016)
Table Italy Phosphodiesterase Inhibitor Sales by Application (2015 and 2016)
Table Italy Phosphodiesterase Inhibitor Market Share by Application (2015 and 2016)
Figure Spain Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
Figure Spain Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
Figure Spain Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
Table Spain Phosphodiesterase Inhibitor Sales by Manufacturers (2015 and 2016)
Table Spain Phosphodiesterase Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Spain Phosphodiesterase Inhibitor Sales by Type (2015 and 2016)
Table Spain Phosphodiesterase Inhibitor Market Share by Type (2015 and 2016)
Table Spain Phosphodiesterase Inhibitor Sales by Application (2015 and 2016)
Table Spain Phosphodiesterase Inhibitor Market Share by Application (2015 and 2016)
Figure Benelux Phosphodiesterase Inhibitor Sales and Growth Rate (2012-2017)
Figure Benelux Phosphodiesterase Inhibitor Revenue and Growth Rate (2012-2017)
Figure Benelux Phosphodiesterase Inhibitor Sales Price Trend (2012-2017)
Table Benelux Phosphodiesterase Inhibitor Sales by Manufacturers (2015 and 2016)
Table Benelux Phosphodiesterase Inhibitor Market Share by Manufacturers (2015 and 2016)
Table Benelux Phosphodiesterase Inhibitor Sales by Type (2015 and 2016)
Table Benelux Phosphodiesterase Inhibitor Market Share by Type (2015 and 2016)
Table Benelux Phosphodiesterase Inhibitor Sales by Application (2015 and 2016)
Table Benelux Phosphodiesterase Inhibitor Market Share by Application (2015 and 2016)
Table Actelion Pharmaceuticals Basic Information List
Table Actelion Pharmaceuticals Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Gilead sciences Basic Information List
Table Gilead sciences Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gilead sciences Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table SteadyMed Basic Information List
Table SteadyMed Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SteadyMed Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Reata Pharmaceuticals Basic Information List
Table Reata Pharmaceuticals Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Phosphodiesterase Inhibitor Sales Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Phosphodiesterase Inhibitor Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Phosphodiesterase Inhibitor
Figure Manufacturing Process Analysis of Phosphodiesterase Inhibitor
Figure Phosphodiesterase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2016
Table Major Buyers of Phosphodiesterase Inhibitor
Table Distributors/Traders List
Figure Germany Phosphodiesterase Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Germany Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure France Phosphodiesterase Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure France Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure UK Phosphodiesterase Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure UK Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Phosphodiesterase Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Russia Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Phosphodiesterase Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Italy Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Phosphodiesterase Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Spain Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Phosphodiesterase Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Table Europe Phosphodiesterase Inhibitor Sales Forecast by Type (2017-2022)
Table Europe Phosphodiesterase Inhibitor Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Actelion Pharmaceuticals
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed
GlaxoSmithKline
Pfizer
Reata Pharmaceuticals
Arena Pharmaceuticals
Merck